Clinical Trial Update: Efficacy and Safety of Combination EMB-001 as a Potential Smoking Cessation Treatment [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial exploring EMB-001 for smoking cessation and tobacco use disorder; efficacy and safety data not provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smoking Cessation
• Tobacco Use Disorder

Drugs mentioned

• EMB-001 (Metyrapone/Oxazepam combination)

Snippet

Sponsor: Rose Research Center, LLC | Conditions: Smoking Cessation, Tobacco Use Disorder | Phase 2, Phase 3 | Status: UNKNOWN